Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Free Cash Flow Generation Index
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Free Cash Flow Generation Index of -0.89x as of December 2023. Free cash flow of CN¥-33.12 Million represents -1% of operating cash flow (CN¥37.03 Million). Read Shandong Keyuan Pharmaceutical Co. Ltd. debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Keyuan Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2021–2023)
Historical FCF Generation Index trend for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. Explore capital reinvestment ratio of Shandong Keyuan Pharmaceutical Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Year-by-year Free Cash Flow Generation Index for Shandong Keyuan Pharmaceutical Co. Ltd. A. For the full company profile including market capitalisation, see 301281 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.89x | CN¥-33.12 Million | CN¥37.03 Million | CN¥70.15 Million | ▼ -222.3% |
| 2022 | 0.73x | CN¥84.75 Million | CN¥115.86 Million | CN¥31.11 Million | ▲ +19.6% |
| 2021 | 0.61x | CN¥31.83 Million | CN¥52.02 Million | CN¥20.19 Million | — |